• Zevra Therapeutics will release third-quarter 2026 corporate and financial results on Nov. 3, 2026, following the market close.
• A conference call and audio webcast will follow at 4:30 p.m. ET that day.
• The webcast replay will be available for 90 days beginning approximately 5:30 p.m. ET on Nov. 3.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zevra Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610200730PRIMZONEFULLFEED9848792) on October 20, 2026, and is solely responsible for the information contained therein.